Related references
Note: Only part of the references are listed.Rapid Reduction in Donor-Specific Anti-Human Leukocyte Antigen Antibodies and Reversal of Antibody-Mediated Rejection With Bortezomib in Pediatric Heart Transplant Patients
William Robert Morrow et al.
TRANSPLANTATION (2012)
Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads
G. Chen et al.
HUMAN IMMUNOLOGY (2011)
Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients
Clifford Chin et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
Allosensitization and outcomes in pediatric heart transplantation
William T. Mahle et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
Reduction of alloantibodies via proteosome inhibition in cardiac transplantation
Jignesh Patel et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
Outcomes of Cardiac Transplantation in Highly Sensitized Pediatric Patients
Victoria Scott et al.
PEDIATRIC CARDIOLOGY (2011)
Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production
D. K. Perry et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Proteasome inhibition for antibody-mediated rejection
Jason J. Everly et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2009)
Bortezomib Can Suppress Activation of Rapamycin-Resistant Memory T Cells Without Affecting Regulatory T-Cell Viability in Non-Human Primates
Jung-Sik Kim et al.
TRANSPLANTATION (2009)
Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection
Matthew J. Everly et al.
TRANSPLANTATION (2008)
Survival in allosensitized children after listing for cardiac transplantation
Brian Feingold et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)
Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy
A. L. Goldberg
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation
Alessio Nencioni et al.
BLOOD (2006)
Use of rituximab to decrease panel-reactive antibodies
IC Balfour et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Pediatric cardiac transplantation in children with high panel reactive antibody
JP Jacobs et al.
ANNALS OF THORACIC SURGERY (2004)
Share Paper
